Suchergebnisse - "Touzeau, Cyrille"

PubPharm (231)

91

Monoclonal antibodies as an addition to current myeloma therapy strategies

enthalten in: Expert review of anticancer therapy | 2021

von Jullien, M. | Touzeau, C. | Moreau, P.

92

Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

enthalten in: American Journal of Hematology | 2021

von Kaufman, J. | Gasparetto, C. | Schjesvold, F. | +18

93

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES) : an open‐label Phase II study

enthalten in: British Journal of Haematology | 2021

von Chari, A. | Rodriguez‐Otero, P. | McCarthy, H. | +18

94

No survival improvement in patients with high‐risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades

enthalten in: British Journal of Haematology | 2021

von Chalopin, T. | Vallet, N. | Theisen, O. | +11

95

A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia

enthalten in: Cancer Medicine | 2021

von Peterlin, P. | Gaschet, J. | Guillaume, T. | +20

96

Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation : Results from the CALM study by the CMWP of the EBMT

enthalten in: European Journal of Haematology | 2021

von Garderet, L. | Sbianchi, G. | Iacobelli, S. | +22

97

Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients

enthalten in: eJHaem | 2021

von Chevallier, P. | Coste‐Burel, M. | Le Bourgeois, A. | +16

98

Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma

enthalten in: Bone marrow transplantation | 2020

von Van de Wyngaert, Z. | Nerich, V. | Fouquet, G. | +25

99

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials

enthalten in: European journal of nuclear medicine and molecular imaging | 2020

von Jamet, B. | Morvan, L. | Nanni, C. | +10

100

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials

enthalten in: European journal of nuclear medicine & molecular imaging | 2020

von Jamet, B. | Morvan, L. | Nanni, C. | +10